STERIS STE Ratios & Valuation
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 176.8%+0.2pp | 176.5%+0.7pp | 175.9%+1.2pp | 174.6%+0.9pp | 173.7%+0.8pp | |
| Operating margin | 69.4%+2.7pp | 66.8%+1.0pp | 65.7%+1.1pp | 64.6%+0.9pp | 63.7%-0.4pp | |
| Net margin | 49%+1.9pp | 47.1%+3.5pp | 43.6%+3.9pp | 39.7%+4.0pp | 35.7%+3.9pp | |
| EBITDA margin | 103.2%+2.2pp | 101.1%+0.3pp | 100.7%+0.2pp | 100.5%-0.7pp | 101.3%-2.7pp | |
| Free cash flow margin | 65.3%+2.1pp | 63.2%+1.8pp | 61.3%+4.1pp | 57.3%+5.0pp | 52.3%+2.3pp | |
| Returns | ||||||
| Return on equity | 41.6%+1.8pp | 39.8%+3.1pp | 36.6%+3.3pp | 33.3%+3.3pp | 30%+3.4pp | |
| Return on assets | 27.3%+1.7pp | 25.6%+2.5pp | 23.1%+2.6pp | 20.5%+2.5pp | 18%+2.3pp | |
| Return on invested capital | 34.9%+2.1pp | 32.7%+1.3pp | 31.4%+1.1pp | 30.3%+0.8pp | 29.5%+0.2pp | |
| Efficiency | ||||||
| Asset turnover | 2.2×+0.1× | 2.2×+0.1× | 2.1×+0.1× | 2.1×0.0× | 2×0.0× | |
| Inventory turnover | 19.7×+0.6× | 19.2×+0.9× | 18.3×+0.7× | 17.6×+0.6× | 17×+0.3× | |
| Liquidity | ||||||
| Current ratio | 9.2×+0.1× | 9×+0.3× | 8.7×0.0× | 8.7×-0.1× | 8.8×-1.1× | |
| Quick ratio | 6.4×+0.2× | 6.3×+0.3× | 5.9×+0.1× | 5.9×0.0× | 5.8×-1.0× | |
| Cash ratio | 1.5×+0.2× | 1.3×+0.3× | 1×+0.1× | 0.9×+0.1× | 0.8×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 1.1×-0.1× | 1.2×-0.1× | 1.3×-0.1× | 1.3×-0.1× | 1.5×-0.2× | |
| Debt-to-assets | 0.7×0.0× | 0.8×0.0× | 0.8×0.0× | 0.9×-0.1× | 0.9×-0.1× | |
| Net debt / EBITDA | 4.3×-0.6× | 4.9×-0.6× | 5.5×-0.5× | 6×-0.5× | 6.4×-0.7× | |
| Interest coverage | 61.4×+8.1× | 53.3×+7.7× | 45.7×+7.7× | 38×+7.1× | 30.9×+4.2× | |
| Valuation | ||||||
| Market capitalization | $94.51B-0.6% | $95.09B+5.1% | $90.5B+0.4% | $90.11B+2.1% | $88.24B+0.1% | |
| Enterprise value | $100.94B-1.1% | $102.03B+4.0% | $98.09B-0.2% | $98.26B+1.3% | $96.96B-1.1% | |
| Price / earnings | 134.7×-8.5× | 143.3×-8.2× | 151.5×-19.8× | 171.2×-17.8× | 189×-22.5× | |
| Price / sales | 16.4×-0.4× | 16.9×+0.5× | 16.3×-0.2× | 16.6×+0.1× | 16.5×-0.2× | |
| Price / book | 13.4×-0.4× | 13.7×+0.3× | 13.4×-0.2× | 13.6×0.0× | 13.6×-0.2× | |
| EV / EBITDA | 68.1×-3.5× | 71.6×+1.2× | 70.4×-1.5× | 71.9×+0.3× | 71.6×0.0× | |
| EV / sales | 17.5×-0.5× | 18.1×+0.4× | 17.7×-0.4× | 18.1×0.0× | 18.1×-0.5× | |
| Free cash flow yield | 16%+1.0pp | 15%0.0pp | 15%+1.1pp | 13.9%+1.1pp | 12.8%+0.7pp | |
| Earnings yield | 12%+0.8pp | 11.2%+0.5pp | 10.6%+1.0pp | 9.6%+0.9pp | 8.7%+1.1pp | |
| Dividend yield | 4%+0.1pp | 3.8%-0.1pp | 3.9%+0.1pp | 3.9%0.0pp | 3.9%+0.1pp | |
| PEG ratio | 2.9×+0.4× | 2.5×— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are STERIS's profit margins?
- STERIS (STE) runs a 44.2% gross margin and a 18.6% operating margin, with a 13.2% net margin.
- Where do STERIS's ratios come from?
- Every ratio is computed from STERIS's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
